Start Submission Become a Reviewer

Reading: Evidence-based management of non-alcoholic fatty liver disease


A- A+
Alt. Display

Clinical Updates

Evidence-based management of non-alcoholic fatty liver disease


S. K. Kodisinghe ,

Colombo North Teaching Hospital, Ragama., LK
About S. K.
University Medical Unit
X close

M. A. Niriella

Colombo North Teaching Hospital, Ragama, and University of Kelaniya, LK
About M. A.
University Medical Unit and Facultu of Medicine
X close


Non-alcoholic fatty liver disease (NAFLD)it is the commonest cause of chronic liver disease in developed countries and is rapidly increasing in the Asia-Pacific region. NAFLD has important long term health implications. There is increased overall mortality most commonly from cardiovascular disease, and also increased liver-related mortality. Treatment options available for NAFLD include general measures at managing obesity and correcting the metabolic syndrome and liver-directed therapies aimed at reducing the liver inflammation and hepatocellular injury. This article reviews the current evidence based management of NAFLD and associated metabolic comorbidities.

Sri Lanka Journal of Diabetes, Endocrinology and Metabolism 2015; 5: 28-33

How to Cite: Kodisinghe, S.K. and Niriella, M.A., 2015. Evidence-based management of non-alcoholic fatty liver disease. Sri Lanka Journal of Diabetes Endocrinology and Metabolism, 5(1), pp.28–33. DOI:
Published on 10 Jul 2015.
Peer Reviewed


comments powered by Disqus